Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Short‐course oral steroids as an adjunct therapy for chronic rhinosinusitis

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD011992Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 18 December 2015see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:
  1. Cochrane ENT Group

Copyright:
  1. Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Lee Yee Chong

    Correspondence to: UK Cochrane Centre, Oxford, UK

    [email protected]

  • Karen Head

    UK Cochrane Centre, Oxford, UK

  • Claire Hopkins

    ENT Department, Guy's Hospital, London, UK

  • Carl Philpott

    Department of Medicine, Norwich Medical School, University of East Anglia, Norwich, UK

  • Martin J Burton

    UK Cochrane Centre, Oxford, UK

Contributions of authors

Lee Yee Chong: scoped, designed and wrote the protocol.

Karen Head: reviewed and edited the protocol.

Claire Hopkins: clinical guidance at all stages of project scoping and protocol development.

Carl Philpott: clinical guidance at all stages of project scoping and protocol development.

Martin J Burton: helped to draft the protocol; clinical guidance at all stages of project scoping and protocol development.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • National Institute for Health Research, UK.

    Funding to complete a suite of reviews on medical interventions for chronic rhinosinusitis in 2015/2016 (award reference 14/174/03), in addition to infrastructure funding for Cochrane ENT

Declarations of interest

Lee Yee Chong: none known.

Karen Head: none known.

Claire Hopkins: I have received financial support from several companies involved in producing instruments for sinus surgery: Acclarent, Sinusys, Cryolife and Medtronic.

Carl Philpott: I have previously received consultancy fees from the companies Acclarent, Navigant, Aerin Medical and Entellus.

Martin J Burton: Martin Burton is Co‐ordinating Editor for the Cochrane ENT Group, but had no role in the editorial process for this protocol.

Acknowledgements

This project is one of a suite of reviews on the medical treatment of chronic rhinosinusitis, funded by the National Institute for Health Research (award reference 14/174/03).

This project was also supported by the National Institute for Health Research, via Cochrane Infrastructure, Cochrane Programme Grant or Cochrane Incentive funding to Cochrane ENT. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.

We are grateful to the external peer reviewer, Professor Wytske Fokkens, the consumer referee and Cochrane ENT editors for their insightful comments, which helped to strengthen this protocol.

Version history

Published

Title

Stage

Authors

Version

2016 Apr 26

Short‐course oral steroids as an adjunct therapy for chronic rhinosinusitis

Review

Karen Head, Lee Yee Chong, Claire Hopkins, Carl Philpott, Anne GM Schilder, Martin J Burton

https://doi.org/10.1002/14651858.CD011992.pub2

2015 Dec 18

Short‐course oral steroids as an adjunct therapy for chronic rhinosinusitis

Protocol

Lee Yee Chong, Karen Head, Claire Hopkins, Carl Philpott, Martin J Burton

https://doi.org/10.1002/14651858.CD011992

Keywords

MeSH

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.